Inventor · disambiguated record
Randy J. Wald
Also filed as: WALD RANDY · WALD RANDY J · WALD RANDY JOSEPH
6 granted patents·14 pending applications·160 citations·filing 1999–2024
82Inventor score
Files withASTELLAS PHARMA INC5BEND RES3BEND RES INC3BOEHRINGER INGELHEIM INT1DAY ONE BIOPHARMACEUTICALS INC1
Top patents by PatentIndex Score
20 records- 0192US11839689B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2022·Granted Dec 12, 2023·2 cites·7 claims
- 0289US12502357B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2024·Granted Dec 23, 2025·0 cites·1 claims
- 0389US6911217B1Controlled release bead, a method of producing the same and multiple unit formulation comprising itPHARMACIA AB·Filed 1999·Granted Jun 28, 2005·136 cites·24 claims
- 0487US2025049721A1Formulations of EnzalutamideASTELLAS PHARMA INC·Filed 2024·Application pending·0 cites
- 0582US12447128B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2022·Granted Oct 21, 2025·0 cites·4 claims
- 0680US9713594B2Methods for making pharmaceutical solid dosage forms of spray-dried dispersionsBEND RES INC·Filed 2013·Granted Jul 25, 2017·3 cites·18 claims
- 0775US7220434B2Dual-release compositions of a cyclooxygenase-2 inhibitorPHARMACIA CORP OF PFIZER INC·Filed 2000·Granted May 22, 2007·19 cites·18 claims
- 0867US2020060976A1Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2019·Application pending·0 cites
- 0964US2019209476A1Formulations of enzalutamideMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 1062US2024182427A1Solid dosage forms of a plasma kallikrein inhibitorREZOLUTE INC·Filed 2023·Application pending·0 cites
- 1162US2014378517A1Formulations of enzalutamideBEND RES·Filed 2014·Application pending·0 cites
- 1260US2017224624A1Formulations of enzalutamideBEND RES INC·Filed 2016·Application pending·0 cites
- 1359US2025221997A1Tyk2 inhibitor formulations and methods of making the sameTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1459US2014179749A1Formulations of enzalutamideBEND RES·Filed 2013·Application pending·0 cites
- 1559US2014100256A1Formulations of enzalutamideBEND RES·Filed 2013·Application pending·0 cites
- 1659US2024226103A1Solid dispersion of a her2 inhibitorBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1758US2017027910A1Formulations of enzalutamideBEND RES INC·Filed 2016·Application pending·0 cites
- 1851US2024041765A1Oral liquid suspension of pan-raf kinase inhibitorDAY ONE BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1950US2007202170A1Dual-release compositions of a cyclooxygenase-2 inhibitorPHARMACIA CORP·Filed 2007·Application pending·0 cites
- 2042US2003152624A1Controlled release dosage form having improved drug release propertiesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Randy J. Wald files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →